Literature DB >> 5425276

The contribution of the sympathetic nervous system to the development and maintenance of experimental hypertension in the rat.

L Finch, G D Leach.   

Abstract

1. Experimental hypertension in the rat, induced either by renal artery stenosis or by treatment with deoxycorticosterone acetate (DCA) developed maximally over a period of 8 weeks. In both types of hypertension the rate of development was unaffected by immunosympathectomy or by chemical sympathectomy following the administration of 6-hydroxydopamine.2. The effect of 6-hydroxydopamine on chronic renal hypertensive rats was to produce a hypotensive action of longer duration than when similarly administered to DCA-induced hypertensive or normotensive rats. Reserpine (5-10 mg/kg intraperitoneally) produced a more marked hypotensive effect on both types of hypertensive rats although it was of much shorter duration.3. It is concluded that experimental hypertension of renal origin or induced by DCA treatment can develop even though most of the sympathetic nervous system has been destroyed. The maintenance of chronic hypertension in these conditions may depend on the adrenal glands or a hormonal system as yet undetected.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5425276      PMCID: PMC1702842          DOI: 10.1111/j.1476-5381.1970.tb12895.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  NEUROGENIC HYPERTENSION IN THE RAT.

Authors:  E M KRIEGER
Journal:  Circ Res       Date:  1964-12       Impact factor: 17.367

2.  Development of a strain of spontaneously hypertensive rats.

Authors:  K OKAMOTO; K AOKI
Journal:  Jpn Circ J       Date:  1963-03

3.  Adrenal glands in the development of renal hypertension in rats.

Authors:  M J FREGLY
Journal:  Am J Physiol       Date:  1957-12

4.  Self-sustaining, post-DCA hypertensive cardiovascular disease.

Authors:  D M GREEN; F J SAUNDERS; N WAHLGREN; R L CRAIG
Journal:  Am J Physiol       Date:  1952-07

5.  DESTRUCTION OF THE SYMPATHETIC GANGLIA IN MAMMALS BY AN ANTISERUM TO A NERVE-GROWTH PROTEIN.

Authors:  R Levi-Montalcini; B Booker
Journal:  Proc Natl Acad Sci U S A       Date:  1960-03       Impact factor: 11.205

6.  Turnover and synthesis of norepinephrine in experimental hypertension in rats.

Authors:  J De Champlain; R A Mueller; J Axelrod
Journal:  Circ Res       Date:  1969-09       Impact factor: 17.367

7.  The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals.

Authors:  L L Iversen; J Glowinski; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1966-02       Impact factor: 4.030

8.  Observations on the pathogenesis of spontaneous inherited hypertension and constricted renalartery hypertension in rats.

Authors:  R LAVERTY; F H SMIRK
Journal:  Circ Res       Date:  1961-03       Impact factor: 17.367

9.  Sustained hypertension following the administration of desoxycorticosterone acetate.

Authors:  S M FRIEDMAN; C L FRIEDMAN; M NAKASHIMA
Journal:  J Exp Med       Date:  1951-04-01       Impact factor: 14.307

10.  Effects of chronia excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension.

Authors:  L K DAHL; M HEINE; L TASSINARI
Journal:  J Exp Med       Date:  1962-06-01       Impact factor: 14.307

View more
  14 in total

1.  Contractile properties of hypertrophied and normal rat hearts [proceedings].

Authors:  R A Brown; A M Solca
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

2.  Central noradrenergic neurons and vascular non-collagen protein in the initial phase of two-kidney, one-clip renovascular hypertension.

Authors:  T Nakada; H Koike; T Katayama
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

3.  Estimation of angiotensin II blood concentrations in hypertensive rats.

Authors:  J R Ballard
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

4.  The importance of central adrenergic neurones in renal hypertension in rabbits.

Authors:  J P Chalmers; C T Dollery; P J Lewis; J L Reid
Journal:  J Physiol       Date:  1974-04       Impact factor: 5.182

5.  Effects of 6-hydroxydopamine on spontaneously hypertensive rats.

Authors:  H Vapaatalo; R Hackman; P Anttila; V Vainionpää; P J Neuvonen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Experimental hypertension of the rat: reciprocal changes of norepinephrine turnover in heart and brain-stem.

Authors:  K Nakamura; M Gerold; H Thoenen
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

Review 7.  6-hydroxydopamine destruction of central adrenergic neurones prevents or reverses developing DOCA-salt hypertension in rats.

Authors:  F Lamprecht; J S Richardson; R B Williams; I J Kopin
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

8.  Cardiovascular reactivity in the experimental hypertensive rat.

Authors:  L Finch
Journal:  Br J Pharmacol       Date:  1971-05       Impact factor: 8.739

9.  Rapid recovery of vascular adrenergic nerves in the rat after chemical sympathectomy with 6-hydroxydopamine.

Authors:  L Finch; G Haeusler; H Kuhn; H Thoenen
Journal:  Br J Pharmacol       Date:  1973-05       Impact factor: 8.739

10.  Resistance of noradrenaline in blood vessels to depletion by 6-hydroxydopamine or immunosympathectomy.

Authors:  B A Berkowitz; S Spector; J H Tarver
Journal:  Br J Pharmacol       Date:  1972-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.